Brain

IRLAB is Granted Additional Patent for Drug Candidate Mesdopetam that Expands its Patent Protection

GOTHENBURG, SWEDEN / ACCESSWIRE / September 4, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 4, 2024 - IRLAB Therapeutics…

4 months ago

Revolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine – Changing the Game in Behavioral Health

SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2024 / In a groundbreaking development for those struggling with nicotine addiction,…

4 months ago

EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations

Support from the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund Strengthens…

4 months ago

Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health

The investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and…

4 months ago

Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H

SAN DIEGO, Sept. 3, 2024 /PRNewswire/ -- Cortechs.ai, the leader in volumetric neuroimaging analysis, announces FDA 510(k) clearance for its NeuroQuant®…

4 months ago

Masimo Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card Today

Shares Details From Recently Unredacted Legal Filings About Quentin Koffey’s Multi-Year Plan to Take Control of MasimoIRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation…

4 months ago

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s…

4 months ago

Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor

NANJING, China, Sept. 2, 2024 /PRNewswire/ -- On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group…

4 months ago

Receipt of Nasdaq Delisting Determination – Plans to Appeal

August 30, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq:…

4 months ago

Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed New Director of Institute for Genome Sciences

Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment BALTIMORE, Aug. 30, 2024 /PRNewswire/ --…

4 months ago